Assignee
LEPIDYNE CO LTD
KR·1 granted patent·5 pending applications·0 citations·filing 2018–2023
Technology mixC12Q6
Top patents by PatentIndex Score
6 records- 0157US2022259676A1Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in geneLEPIDYNE CO LTD·Filed 2022·Application pending·0 cites
- 0249US2025270639A1Composition for determining whether nucleic acid is methylated and method for determining whether nucleic acid is methylatedLEPIDYNE CO LTD·Filed 2023·Application pending·0 cites
- 0349US2021147943A1Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in geneLEPIDYNE CO LTD·Filed 2018·Application pending·0 cites
- 0445US2022228224A1Method for determining whether biological sample hasoriginated from liver cancer tissueLEPIDYNE CO LTD·Filed 2022·Application pending·0 cites
- 0535US12467097B2DNA methylation marker for predicting recurrence of liver cancer, and use thereofLEPIDYNE CO LTD·Filed 2020·Granted Nov 11, 2025·0 cites·4 claims
- 0635US2023257812A1Method for determining if origin of biological sample is from liver tissueLEPIDYNE CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LEPIDYNE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →